Copyright Reports & Markets. All rights reserved.

Global Regenerative Medicine Market Growth 2019-2024

Buy now

Table of Contents

    2019-2024 Global Regenerative Medicine Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Regenerative Medicine Consumption 2014-2024
        • 2.1.2 Regenerative Medicine Consumption CAGR by Region
      • 2.2 Regenerative Medicine Segment by Type
        • 2.2.1 Mono Avalanche Airbags
        • 2.2.2 Dual Avalanche Airbags
      • 2.3 Regenerative Medicine Consumption by Type
        • 2.3.1 Global Regenerative Medicine Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Regenerative Medicine Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Regenerative Medicine Sale Price by Type (2014-2019)
      • 2.4 Regenerative Medicine Segment by Application
        • 2.4.1 Skiing
        • 2.4.2 Climbing
        • 2.4.3 Hiking
        • 2.4.4 Others
      • 2.5 Regenerative Medicine Consumption by Application
        • 2.5.1 Global Regenerative Medicine Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Regenerative Medicine Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Regenerative Medicine Sale Price by Application (2014-2019)

      3 Global Regenerative Medicine by Players

      • 3.1 Global Regenerative Medicine Sales Market Share by Players
        • 3.1.1 Global Regenerative Medicine Sales by Players (2017-2019)
        • 3.1.2 Global Regenerative Medicine Sales Market Share by Players (2017-2019)
      • 3.2 Global Regenerative Medicine Revenue Market Share by Players
        • 3.2.1 Global Regenerative Medicine Revenue by Players (2017-2019)
        • 3.2.2 Global Regenerative Medicine Revenue Market Share by Players (2017-2019)
      • 3.3 Global Regenerative Medicine Sale Price by Players
      • 3.4 Global Regenerative Medicine Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Regenerative Medicine Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Regenerative Medicine Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Regenerative Medicine by Regions

      • 4.1 Regenerative Medicine by Regions
        • 4.1.1 Global Regenerative Medicine Consumption by Regions
        • 4.1.2 Global Regenerative Medicine Value by Regions
      • 4.2 Americas Regenerative Medicine Consumption Growth
      • 4.3 APAC Regenerative Medicine Consumption Growth
      • 4.4 Europe Regenerative Medicine Consumption Growth
      • 4.5 Middle East & Africa Regenerative Medicine Consumption Growth

      5 Americas

      • 5.1 Americas Regenerative Medicine Consumption by Countries
        • 5.1.1 Americas Regenerative Medicine Consumption by Countries (2014-2019)
        • 5.1.2 Americas Regenerative Medicine Value by Countries (2014-2019)
      • 5.2 Americas Regenerative Medicine Consumption by Type
      • 5.3 Americas Regenerative Medicine Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Regenerative Medicine Consumption by Countries
        • 6.1.1 APAC Regenerative Medicine Consumption by Countries (2014-2019)
        • 6.1.2 APAC Regenerative Medicine Value by Countries (2014-2019)
      • 6.2 APAC Regenerative Medicine Consumption by Type
      • 6.3 APAC Regenerative Medicine Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Regenerative Medicine by Countries
        • 7.1.1 Europe Regenerative Medicine Consumption by Countries (2014-2019)
        • 7.1.2 Europe Regenerative Medicine Value by Countries (2014-2019)
      • 7.2 Europe Regenerative Medicine Consumption by Type
      • 7.3 Europe Regenerative Medicine Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Regenerative Medicine by Countries
        • 8.1.1 Middle East & Africa Regenerative Medicine Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Regenerative Medicine Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Regenerative Medicine Consumption by Type
      • 8.3 Middle East & Africa Regenerative Medicine Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.2 Regenerative Medicine Distributors
      • 10.3 Regenerative Medicine Customer

      11 Global Regenerative Medicine Market Forecast

      • 11.1 Global Regenerative Medicine Consumption Forecast (2019-2024)
      • 11.2 Global Regenerative Medicine Forecast by Regions
        • 11.2.1 Global Regenerative Medicine Forecast by Regions (2019-2024)
        • 11.2.2 Global Regenerative Medicine Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Regenerative Medicine Forecast by Type
      • 11.8 Global Regenerative Medicine Forecast by Application

      12 Key Players Analysis

      • 12.1 ABS Protection GmbH
        • 12.1.1 Company Details
        • 12.1.2 Regenerative Medicine Product Offered
        • 12.1.3 ABS Protection GmbH Regenerative Medicine Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 ABS Protection GmbH News
      • 12.2 Mammut
        • 12.2.1 Company Details
        • 12.2.2 Regenerative Medicine Product Offered
        • 12.2.3 Mammut Regenerative Medicine Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Mammut News
      • 12.3 Clarus Corporation
        • 12.3.1 Company Details
        • 12.3.2 Regenerative Medicine Product Offered
        • 12.3.3 Clarus Corporation Regenerative Medicine Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 Clarus Corporation News
      • 12.4 Backcountry Access
        • 12.4.1 Company Details
        • 12.4.2 Regenerative Medicine Product Offered
        • 12.4.3 Backcountry Access Regenerative Medicine Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Backcountry Access News
      • 12.5 Scott
        • 12.5.1 Company Details
        • 12.5.2 Regenerative Medicine Product Offered
        • 12.5.3 Scott Regenerative Medicine Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 Scott News
      • 12.6 Ortovox
        • 12.6.1 Company Details
        • 12.6.2 Regenerative Medicine Product Offered
        • 12.6.3 Ortovox Regenerative Medicine Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Ortovox News
      • 12.7 ARVA
        • 12.7.1 Company Details
        • 12.7.2 Regenerative Medicine Product Offered
        • 12.7.3 ARVA Regenerative Medicine Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 ARVA News
      • 12.8 Osprey Packs
        • 12.8.1 Company Details
        • 12.8.2 Regenerative Medicine Product Offered
        • 12.8.3 Osprey Packs Regenerative Medicine Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.8.4 Main Business Overview
        • 12.8.5 Osprey Packs News
      • 12.9 The North Face
        • 12.9.1 Company Details
        • 12.9.2 Regenerative Medicine Product Offered
        • 12.9.3 The North Face Regenerative Medicine Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.9.4 Main Business Overview
        • 12.9.5 The North Face News
      • 12.10 Dakine
        • 12.10.1 Company Details
        • 12.10.2 Regenerative Medicine Product Offered
        • 12.10.3 Dakine Regenerative Medicine Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.10.4 Main Business Overview
        • 12.10.5 Dakine News
      • 12.11 Mystery Ranch
      • 12.12 Millet(Calida Group)
      • 12.13 Motorfist
      • 12.14 Deuter

      13 Research Findings and Conclusion

      Avalanche airbags are safety gear designed to prevent the wearer from being buried while skiing and mountaineering. In an avalanche, larger objects rise to the surface, while smaller objects sink to the bottom. An airbag system incorporated into a backpack, with a large balloon or balloons that inflates at the pull of a cord, is designed to make the person wearing it larger so that they naturally rise to the surface of the snow.
      With the rising popularity of ski touring and freeriding many manufacturers notice that there is a need for more protection while being in the freedom of backcountry or high alpine. So nowadays, avalanche airbag backpack became a usual piece of equipment next to your regular avalanche safety equipment: avalanche beacon, probe, and shovel. And thanks to a high demand for this piece of equipment, avalanche airbag backpacks are no longer considered a luxury good but are getting more and more affordable each season. But avalanche airbag packs are only helpful in critical situations of avalanche slides, they in no way guarantee survival and they are not meant to be used as the only mean of protection, and uncertainties related to survival percentages is limiting growth for the Avalanche Airbags market.
      Direct-to-consumer is the most lucrative sales channel for avalanche airbags. Consumer familiarity, and availability of a wide range remain the key USPs of this sales channel. Specialty stores follow suit. These two sales channels collectively account for nearly two-third of all avalanche airbags sold globally.

      According to this study, over the next five years the Regenerative Medicine market will register a 6.0% CAGR in terms of revenue, the global market size will reach US$ 260 million by 2024, from US$ 190 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Regenerative Medicine business, shared in Chapter 3.

      This report presents a comprehensive overview, market shares, and growth opportunities of Regenerative Medicine market by product type, application, key manufacturers and key regions and countries.

      This study considers the Regenerative Medicine value and volume generated from the sales of the following segments:

      Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
      Mono Avalanche Airbags
      Dual Avalanche Airbags
      Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
      Skiing
      Climbing
      Hiking
      Others

      This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
      ABS Protection GmbH
      Mammut
      Clarus Corporation
      Backcountry Access
      Scott
      Ortovox
      ARVA
      Osprey Packs
      The North Face
      Dakine
      Mystery Ranch
      Millet(Calida Group)
      Motorfist
      Deuter

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global Regenerative Medicine consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
      To understand the structure of Regenerative Medicine market by identifying its various subsegments.
      Focuses on the key global Regenerative Medicine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Regenerative Medicine with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the consumption of Regenerative Medicine submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.

      Buy now